V.Sagar Sethi

1.1k total citations
44 papers, 936 citations indexed

About

V.Sagar Sethi is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, V.Sagar Sethi has authored 44 papers receiving a total of 936 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 11 papers in Oncology and 9 papers in Pharmacology. Recurrent topics in V.Sagar Sethi's work include DNA and Nucleic Acid Chemistry (7 papers), Cancer Treatment and Pharmacology (7 papers) and Neuropeptides and Animal Physiology (6 papers). V.Sagar Sethi is often cited by papers focused on DNA and Nucleic Acid Chemistry (7 papers), Cancer Treatment and Pharmacology (7 papers) and Neuropeptides and Animal Physiology (6 papers). V.Sagar Sethi collaborates with scholars based in United States, Germany and United Kingdom. V.Sagar Sethi's co-authors include Don V. Jackson, Wolfram Zillig, Charles L. Spurr, Hayat Önyüksel, Israel Rubinstein, Dietmar Rabussay, Peter Palm, W. Seifert, Kasper Zechel and Melitta Schachner and has published in prestigious journals such as Cancer, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

V.Sagar Sethi

42 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V.Sagar Sethi United States 17 530 249 147 95 93 44 936
M.C. Bibby United Kingdom 17 495 0.9× 283 1.1× 77 0.5× 155 1.6× 50 0.5× 39 1.0k
Danuta Duś Poland 23 776 1.5× 378 1.5× 75 0.5× 205 2.2× 38 0.4× 106 1.5k
Lesley Sutherland United Kingdom 12 419 0.8× 143 0.6× 69 0.5× 33 0.3× 87 0.9× 16 835
Gary B. Henderson United States 26 841 1.6× 418 1.7× 94 0.6× 91 1.0× 27 0.3× 67 1.8k
Chris J. Delves United Kingdom 12 518 1.0× 139 0.6× 451 3.1× 75 0.8× 36 0.4× 12 1.1k
Vanessa Gurtu United States 7 743 1.4× 108 0.4× 171 1.2× 81 0.9× 22 0.2× 7 1.1k
Fuxing Tang United States 15 541 1.0× 332 1.3× 199 1.4× 67 0.7× 95 1.0× 23 895
A. Čihák Czechia 20 1.1k 2.1× 185 0.7× 74 0.5× 217 2.3× 59 0.6× 125 1.6k
John P. Durham United States 17 876 1.7× 130 0.5× 82 0.6× 58 0.6× 22 0.2× 41 1.1k
Mohamed Amessou France 17 746 1.4× 352 1.4× 100 0.7× 73 0.8× 17 0.2× 33 1.6k

Countries citing papers authored by V.Sagar Sethi

Since Specialization
Citations

This map shows the geographic impact of V.Sagar Sethi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.Sagar Sethi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.Sagar Sethi more than expected).

Fields of papers citing papers by V.Sagar Sethi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V.Sagar Sethi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.Sagar Sethi. The network helps show where V.Sagar Sethi may publish in the future.

Co-authorship network of co-authors of V.Sagar Sethi

This figure shows the co-authorship network connecting the top 25 collaborators of V.Sagar Sethi. A scholar is included among the top collaborators of V.Sagar Sethi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V.Sagar Sethi. V.Sagar Sethi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sethi, V.Sagar & Michael Marks. (2025). Neurosyphilis in 2025. Current Opinion in Neurology. 38(4). 397–405.
2.
Eisen, Damon P., Elizabeth Hamilton, Jacob Bodilsen, et al.. (2022). Longer than 2 hours to antibiotics is associated with doubling of mortality in a multinational community-acquired bacterial meningitis cohort. Scientific Reports. 12(1). 672–672. 13 indexed citations
3.
Sethi, V.Sagar & Nicholas Davies. (2020). Acute neurological infections. Medicine. 48(9). 575–580. 1 indexed citations
4.
Sethi, V.Sagar, et al.. (2012). Novel, Biocompatible, and Disease Modifying VIP Nanomedicine for Rheumatoid Arthritis. Molecular Pharmaceutics. 10(2). 728–738. 45 indexed citations
5.
Önyüksel, Hayat, V.Sagar Sethi, Guy Weinberg, Pradeep K. Dudeja, & Israel Rubinstein. (2007). Bupivacaine, but not lidocaine, disrupts cardiolipin-containing small biomimetic unilamellar liposomes. Chemico-Biological Interactions. 169(3). 154–159. 23 indexed citations
6.
Sethi, V.Sagar, Hayat Önyüksel, & Israel Rubinstein. (2005). Liposomal Vasoactive Intestinal Peptide. Methods in enzymology on CD-ROM/Methods in enzymology. 391. 377–395. 33 indexed citations
7.
Sethi, V.Sagar, et al.. (2004). Helospectin I and II evoke vasodilation in the intact peripheral microcirculation. Peptides. 25(1). 65–69. 5 indexed citations
8.
Önyüksel, Hayat, et al.. (2003). Interactions of VIP with rigid phospholipid bilayers: implications for vasoreactivity. Peptides. 24(2). 281–286. 8 indexed citations
9.
Rubinstein, Israel, et al.. (2001). Liposomal VIP potentiates DNA synthesis in cultured oral keratinocytes. Peptides. 22(4). 671–675. 9 indexed citations
10.
Önyüksel, Hayat, et al.. (2000). Surface-active properties of vasoactive intestinal peptide☆. Peptides. 21(3). 419–423. 16 indexed citations
11.
Thimmaiah, Kuntebommanahalli N. & V.Sagar Sethi. (1990). Structural investigations of the products of vincristine sulfate formed after in vitro incubation of the alkaloid in bile of dogs. Microchemical Journal. 41(3). 320–326. 2 indexed citations
12.
Sethi, V.Sagar & Kuntebommanahalli N. Thimmaiah. (1985). Structural studies on the degradation products of vincristine dihydrogen sulfate.. PubMed. 45(11 Pt 1). 5386–9. 17 indexed citations
13.
Jackson, Don V., et al.. (1984). Pharmacokinetics of vindesine bolus and infusion. Cancer Chemotherapy and Pharmacology. 13(2). 114–119. 11 indexed citations
14.
Jackson, Don V., Wayne Meredith, V.Sagar Sethi, et al.. (1983). Continuous intravenous infusion of vinca alkaloid using a subcutaneously implanted pump in a canine model. Cancer Chemotherapy and Pharmacology. 10(3). 217–220. 5 indexed citations
15.
Sethi, V.Sagar, Jon Lewis, & Richard W. St. Clair. (1983). Vincristine and vinblastine lower plasma cholesterol concentrations in rhesus monkeys. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 752(3). 482–487. 3 indexed citations
16.
Sethi, V.Sagar. (1976). Inhibition of mammalian and oncornavirus nucleic acid polymerase activities by alkoxybenzophenanthridine alkaloids.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 36(7 PT 1). 2390–5. 29 indexed citations
17.
Sethi, V.Sagar. (1975). Mechanism of polyadenylate polymerase: Formation of enzyme‐substrate and enzyme‐primer complexes. FEBS Letters. 59(1). 3–7. 2 indexed citations
18.
Sethi, V.Sagar. (1971). Structure and function of DNA-dependent RNA-polymerase. Progress in Biophysics and Molecular Biology. 23. 67–101. 21 indexed citations
19.
Zillig, Wolfram, Kasper Zechel, Dietmar Rabussay, et al.. (1970). On the Rule of Different Subunits of DNA-Dependent RNA Polymerase from E. coli in the Transcription Process. Cold Spring Harbor Symposia on Quantitative Biology. 35(0). 47–58. 175 indexed citations
20.
Sethi, V.Sagar, Wolfram Zillig, & Heinz Bauer. (1970). Dissociation and reconstitution of active DNA‐dependent RNA‐polymerase from E. coli. FEBS Letters. 8(5). 236–239. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.C. Bibby Breakdown of academic impact, for papers by Danuta Duś Breakdown of academic impact, for papers by Lesley Sutherland Breakdown of academic impact, for papers by Gary B. Henderson Breakdown of academic impact, for papers by Chris J. Delves Breakdown of academic impact, for papers by Vanessa Gurtu Breakdown of academic impact, for papers by Fuxing Tang Breakdown of academic impact, for papers by A. Čihák Breakdown of academic impact, for papers by John P. Durham Breakdown of academic impact, for papers by Mohamed Amessou
Rankless by CCL
2026